Jesús Martín-Sánchez

6PUBLICATIONS
50CO-AUTHORS
Haematological tumoursPharmacogenomicsMedical mycologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain

|Sep 21, 2022
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma.

María Victoria Mateos, Felipe Prosper, Jesús Martin Sánchez

|Jun 06, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.

Juan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig

|Apr 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.

Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol

|May 22, 2021
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.

Noemi Puig, Miguel T Hernández, Laura Rosiñol

|Mar 29, 2021
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.

Cristina Pascual-Izquierdo, Julio Del Rio-Garma, Javier de la Rubia

Pageof 1

Frequent Collaborators

5 joint publications

María-Victoria Mateos

4 joint publications

Albert Ortiol

4 joint publications

Jesús F San-Miguel

4 joint publications

Juan-José Lahuerta